{"name":"Epitopoietic Research Corporation","slug":"epitopoietic-research-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNQmVQMTFxeVVDOGdvN29DUW15VnRVTHgxR1VMVXgyTTJ1TFl3V05HTVJWY3VCWGFXZXlYMnUzMThYRkFic1pFWWUzWFRteTRZdFVxNkk2RGpxQXd0NGNKaWg3ZTUyR3JQTVpHbHBlZGZ3SHc0ZGU0U1l3TmtoN3laM2Y3NXNkVUxqWFhRV0xRd2pWLUVSNFJFQ05oZjBIeEhCSUFhVTdQY3R6bEQzTksyNDV4LWpvRUZoU2M2bmZHMmp0dDliRHJvMU9QWEJ6b1BndWJxb3NvWWRxWjA0cXpia012dDlyR25POXZid0JISC1uU0VKX2c?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQY0EyRFZ3NjVXbWN2Mzh2aDNJZS1GR3pmR3d4VHd1MUxMVElCb21LYjdUQjctZUcyQ1NJY1BKWldKVkpnZVRVMVhHZVRhUVViZHAyejBtMnRxSlFlV0xfaGdhVC0wd2huQi13Tk5uUGpjWGFkX1pHNGVHWDF2UnFQdUdmVF9WSHowcVlab1ZJbUxvSFBKcWc?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxQOGdNMTN1RElfTmhkU0xLTTZlV3Z4OTNEUjFyYjJLNzVjaFdUbDVHSjFrUXREZjAyLXF5clh4Q2x4U29Eb2loQkttODdYOVlUd2hFZkxPOEJDV0xIdEQ1OGZEaUQxMHVCR09NLS1Cd19QS0JxX3M5Q1I2RGtHQUpxTlZ2ZGpvUTNJdVo5ejQ5MGktaC1fdE85MnliWVc5eHpwdnZyMXhQU1d5N01MX3ItZktMLTd0bW5fcTVxNDVOeU44YnFSd3FjVWt6LXhhcXRadnAtRGlNYTR4MmlQbkNaY01fZTJLek1vWXdfRzZxV1FKSVNXV0RwbThRR21NNUlwbFExSG9CVnhuLVhiZFlkWHYwYXdJQzR3SGZSQzl6MS1HRjVZOTNKTTVzdm1RTmRwRVc0MWdrMTVMa2RQRTFaSlZncFNKVGJBYS1ibzdBNHI?oc=5","date":"2026-03-19","type":"pipeline","source":"Barchart.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Bar","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQTWE5bUN3RXk0aDJSUmFRSVFJYkdYemFGc21xY2VKYWZvYzBGZUtfejQwdXdsaWc4NVhYRHBhaWt6SDJILTJwTi1aamRqeHZkUkhMNThnbzViU3FFelNuRktzYWpjOHNMNHJkRzYyTjdmekh1U2paeVNfa25hOHNCeGVvY3U2OURreXdhMHVwclNKM1ZWR2k2Q1BLRHd2QTdxcXNQWkRsdW5fd3dfOGkyUXpvZk9JRGNwWV9HNjNnMTlObWlDZU1WV25EN29XMGN6UTJQUzV2XzloQ2FuX203b1RDVGotdGpYb3FnOFN3M25jR25ITkRmd2cxY3o3dGx1cFN5WFJFb0xXdFQ0OEU3VFZsZUxCTXdoYjVvVFh0TUxRQWpuQXVONU9YQURJWlJF?oc=5","date":"2025-09-23","type":"trial","source":"GlobeNewswire","summary":"TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ - GlobeNewswire","headline":"TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-12-23","type":"pipeline","source":"GlobeNewswire","summary":"Glioblastoma Multiforme Treatment (GBM) Market Research - GlobeNewswire","headline":"Glioblastoma Multiforme Treatment (GBM) Market Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPNmpfLURDcHUtWEZWbFFvMEpwRlBnSE0zcUhPXzAtNzRmT1JNbGR2QlhVZzRqX0hsbl95ZnV1YlpTTkJud1ZSYmNHbWh5WHZ2UHBoUXhhRXdyQVBQNXAyRHliN1FhNTA1NElRekVjNDUwUXh0bVh0dm9MVmYzVUFjRlpDM1lqZTA?oc=5","date":"2019-01-17","type":"pipeline","source":"Cancer Health","summary":"First Patient Takes Advantage of Right to Try Law - Cancer Health","headline":"First Patient Takes Advantage of Right to Try Law","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTjhNQnpFOFoyNzM1OXhGRmVHTHJlNU5RdmNLaGMybE1QVkFQWVlhNlRvbmxFSk1RalJoTkEzTnpnQWhVSkE3b0FPdkU2V2F0eVdSTXk3emhYdGRkZ1EtWVBqN2RqXzl4cTU5QWtJZGlNZG9RaUVmY2RrVVNxbzFGb2NGZXhKNFluQjNKN3otZy1TTW9LUU14dkIzZHM5dHFpWlU0d2xpUUs?oc=5","date":"2019-01-10","type":"pipeline","source":"fiercebiotech.com","summary":"ERC cancer vaccine is first drug to be given to a 'right-to-try' patient - fiercebiotech.com","headline":"ERC cancer vaccine is first drug to be given to a 'right-to-try' patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPU25mRHNoZlV4aUhWZWNZS2hjVHU2bnZjWHpaM3B1S1NaZFFPYVQ1cXBoSmNLZ0JmRnJsUk5ldGFDMEM2MUZlZDNfUEZPdnNkSGlDeGlUR051SlVna0ppQ0F5WmlZd2l5cEoxUTl6aE9yLUZBODBweUhVOHktSDdHRDNQRDFuMW90SDlSYklxeUJONkI3ZzYxSHlaQ1A?oc=5","date":"2019-01-10","type":"pipeline","source":"BioSpace","summary":"Glioblastoma Patient Is First to Be Given Right to Try Experimental Drug in California - BioSpace","headline":"Glioblastoma Patient Is First to Be Given Right to Try Experimental Drug in California","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}